化學材料

Labetuzumab (anti-CEACAM5) ExactAb™, Validated, Carrier Free, Low Endotoxin, Azide Free, Recombinant, ≥95%(SDS-PAGE&SEC), Lot by Lot
加入洽詢
Labetuzumab govitecan (anti-CEACAM5) ExactAb™, 重組, 已驗證, 無疊氮鈉, 低內毒素, 無載體, ≥90%(SDS-PAGE&SEC), Lot by Lot
加入洽詢
Labetuzumab govitecan (anti-CEACAM5) ExactAb™, 重組, 已驗證, 無疊氮鈉, 低內毒素, 無載體, ≥90%(SDS-PAGE&SEC), Lot by Lot
加入洽詢
Labetuzumab govitecan (anti-CEACAM5) ExactAb™, 重組, 已驗證, 無疊氮鈉, 低內毒素, 無載體, ≥90%(SDS-PAGE&SEC), Lot by Lot
加入洽詢
Labetuzumab govitecan (anti-CEACAM5) ExactAb™, 重組, 已驗證, 無疊氮鈉, 低內毒素, 無載體, ≥90%(SDS-PAGE&SEC), Lot by Lot
加入洽詢
Lampalizumab (anti-Complement Factor D) ExactAb™, Validated, Carrier Free, Low Endotoxin, Azide Free, Recombinant, ≥95%(SDS-PAGE&SEC), Lot by Lot
加入洽詢
Lampalizumab (anti-Complement Factor D) ExactAb™, Validated, Carrier Free, Low Endotoxin, Azide Free, Recombinant, ≥95%(SDS-PAGE&SEC), Lot by Lot
加入洽詢
Lampalizumab (anti-Complement Factor D) ExactAb™, Validated, Carrier Free, Low Endotoxin, Azide Free, Recombinant, ≥95%(SDS-PAGE&SEC), Lot by Lot
加入洽詢
Lampalizumab (anti-Complement Factor D) ExactAb™, Validated, Carrier Free, Low Endotoxin, Azide Free, Recombinant, ≥95%(SDS-PAGE&SEC), Lot by Lot
加入洽詢
Landogrozumab (anti-GDF8) ExactAb™, Validated, Carrier Free, Low Endotoxin, Azide Free, Recombinant, ≥95%(SDS-PAGE&SEC), Lot by Lot
加入洽詢
Landogrozumab (anti-GDF8) ExactAb™, Validated, Carrier Free, Low Endotoxin, Azide Free, Recombinant, ≥95%(SDS-PAGE&SEC), Lot by Lot
加入洽詢
Landogrozumab (anti-GDF8) ExactAb™, Validated, Carrier Free, Low Endotoxin, Azide Free, Recombinant, ≥95%(SDS-PAGE&SEC), Lot by Lot
加入洽詢
Landogrozumab (anti-GDF8) ExactAb™, Validated, Carrier Free, Low Endotoxin, Azide Free, Recombinant, ≥95%(SDS-PAGE&SEC), Lot by Lot
加入洽詢
Lecanemab (anti-Amyloid Beta) ExactAb™, Validated, Carrier Free, Low Endotoxin, Azide Free, Recombinant, ≥95%(SDS-PAGE&SEC), Lot by Lot
加入洽詢
Lecanemab (anti-Amyloid Beta) ExactAb™, Validated, Carrier Free, Low Endotoxin, Azide Free, Recombinant, ≥95%(SDS-PAGE&SEC), Lot by Lot
加入洽詢
Lecanemab (anti-Amyloid Beta) ExactAb™, Validated, Carrier Free, Low Endotoxin, Azide Free, Recombinant, ≥95%(SDS-PAGE&SEC), Lot by Lot
加入洽詢
Lecanemab (anti-Amyloid Beta) ExactAb™, Validated, Carrier Free, Low Endotoxin, Azide Free, Recombinant, ≥95%(SDS-PAGE&SEC), Lot by Lot
加入洽詢
Lenzilumab (anti-GM-CSF) ExactAb™, Validated, Carrier Free, Low Endotoxin, Azide Free, Recombinant, ≥95%(SDS-PAGE&SEC), Lot by Lot
加入洽詢
Lenzilumab (anti-GM-CSF) ExactAb™, Validated, Carrier Free, Low Endotoxin, Azide Free, Recombinant, ≥95%(SDS-PAGE&SEC), Lot by Lot
加入洽詢
Lenzilumab (anti-GM-CSF) ExactAb™, Validated, Carrier Free, Low Endotoxin, Azide Free, Recombinant, ≥95%(SDS-PAGE&SEC), Lot by Lot
加入洽詢
Lenzilumab (anti-GM-CSF) ExactAb™, Validated, Carrier Free, Low Endotoxin, Azide Free, Recombinant, ≥95%(SDS-PAGE&SEC), Lot by Lot
加入洽詢
lepunafusp alfa Moligand™

lepunafusp alfa Moligand™

AB175577-1MG / 1MG
加入洽詢
lepunafusp alfa Moligand™

lepunafusp alfa Moligand™

AB175577-5MG / 5MG
加入洽詢
Lifastuzumab vedotin (anti-SLC34A2) ExactAb™, 重組, 已驗證, 無疊氮鈉, 低內毒素, 無載體, ≥90%(SDS-PAGE&SEC), Lot by Lot
加入洽詢
Lifastuzumab vedotin (anti-SLC34A2) ExactAb™, 重組, 已驗證, 無疊氮鈉, 低內毒素, 無載體, ≥90%(SDS-PAGE&SEC), Lot by Lot
加入洽詢
Lifastuzumab vedotin (anti-SLC34A2) ExactAb™, 重組, 已驗證, 無疊氮鈉, 低內毒素, 無載體, ≥90%(SDS-PAGE&SEC), Lot by Lot
加入洽詢
Lifastuzumab vedotin (anti-SLC34A2) ExactAb™, 重組, 已驗證, 無疊氮鈉, 低內毒素, 無載體, ≥90%(SDS-PAGE&SEC), Lot by Lot
加入洽詢
Ligelizumab (anti-IgE) ExactAb™, Validated, Carrier Free, Low Endotoxin, Azide Free, Recombinant, ≥95%(SDS-PAGE&SEC), Lot by Lot
加入洽詢
Ligelizumab (anti-IgE) ExactAb™, Validated, Carrier Free, Low Endotoxin, Azide Free, Recombinant, ≥95%(SDS-PAGE&SEC), Lot by Lot
加入洽詢
Ligelizumab (anti-IgE) ExactAb™, Validated, Carrier Free, Low Endotoxin, Azide Free, Recombinant, ≥95%(SDS-PAGE&SEC), Lot by Lot
加入洽詢
Ligelizumab (anti-IgE) ExactAb™, Validated, Carrier Free, Low Endotoxin, Azide Free, Recombinant, ≥95%(SDS-PAGE&SEC), Lot by Lot
加入洽詢
Lilotomab (anti-TSPAN26) ExactAb™, Validated, Carrier Free, Low Endotoxin, Azide Free, Recombinant, ≥95%(SDS-PAGE&SEC), Lot by Lot
加入洽詢
Lilotomab (anti-TSPAN26) ExactAb™, Validated, Carrier Free, Low Endotoxin, Azide Free, Recombinant, ≥95%(SDS-PAGE&SEC), Lot by Lot
加入洽詢
Lilotomab (anti-TSPAN26) ExactAb™, Validated, Carrier Free, Low Endotoxin, Azide Free, Recombinant, ≥95%(SDS-PAGE&SEC), Lot by Lot
加入洽詢
Lilotomab (anti-TSPAN26) ExactAb™, Validated, Carrier Free, Low Endotoxin, Azide Free, Recombinant, ≥95%(SDS-PAGE&SEC), Lot by Lot
加入洽詢
Lintuzumab (anti-CD33) Carrier Free, 重組, ExactAb™, Low Endotoxin, Azide Free, Validated, ≥95%(SDS-PAGE&SEC), Lot by Lot
加入洽詢
Lintuzumab (anti-CD33) Carrier Free, 重組, ExactAb™, Low Endotoxin, Azide Free, Validated, ≥95%(SDS-PAGE&SEC), Lot by Lot
加入洽詢
Lintuzumab (anti-CD33) Carrier Free, 重組, ExactAb™, Low Endotoxin, Azide Free, Validated, ≥95%(SDS-PAGE&SEC), Lot by Lot
加入洽詢
Lintuzumab (anti-CD33) Carrier Free, 重組, ExactAb™, Low Endotoxin, Azide Free, Validated, ≥95%(SDS-PAGE&SEC), Lot by Lot
加入洽詢
Lirilumab (anti-KIR) ExactAb™, Validated, Carrier Free, Low Endotoxin, Azide Free, Recombinant, ≥95%(SDS-PAGE&SEC), Lot by Lot
加入洽詢
Lirilumab (anti-KIR) ExactAb™, Validated, Carrier Free, Low Endotoxin, Azide Free, Recombinant, ≥95%(SDS-PAGE&SEC), Lot by Lot
加入洽詢
Lirilumab (anti-KIR) ExactAb™, Validated, Carrier Free, Low Endotoxin, Azide Free, Recombinant, ≥95%(SDS-PAGE&SEC), Lot by Lot
加入洽詢
Lirilumab (anti-KIR) ExactAb™, Validated, Carrier Free, Low Endotoxin, Azide Free, Recombinant, ≥95%(SDS-PAGE&SEC), Lot by Lot
加入洽詢
Livmoniplimab (anti-LRRC32/TGFβ1) ExactAb™, Validated, Carrier Free, Low Endotoxin, Azide Free, 重組, ≥95%(SDS-PAGE&SEC), Lot by Lot
加入洽詢
Livmoniplimab (anti-LRRC32/TGFβ1) ExactAb™, Validated, Carrier Free, Low Endotoxin, Azide Free, 重組, ≥95%(SDS-PAGE&SEC), Lot by Lot
加入洽詢
Livmoniplimab (anti-LRRC32/TGFβ1) ExactAb™, Validated, Carrier Free, Low Endotoxin, Azide Free, 重組, ≥95%(SDS-PAGE&SEC), Lot by Lot
加入洽詢
Livmoniplimab (anti-LRRC32/TGFβ1) ExactAb™, Validated, Carrier Free, Low Endotoxin, Azide Free, 重組, ≥95%(SDS-PAGE&SEC), Lot by Lot
加入洽詢
Lorvotuzumab mertansine (anti-NCAM1) ExactAb™, 重組, 已驗證, 無疊氮鈉, 低內毒素, 無載體, ≥90%(SDS-PAGE&SEC), Lot by Lot
加入洽詢
Lorvotuzumab mertansine (anti-NCAM1) ExactAb™, 重組, 已驗證, 無疊氮鈉, 低內毒素, 無載體, ≥90%(SDS-PAGE&SEC), Lot by Lot
加入洽詢
Lorvotuzumab mertansine (anti-NCAM1) ExactAb™, 重組, 已驗證, 無疊氮鈉, 低內毒素, 無載體, ≥90%(SDS-PAGE&SEC), Lot by Lot
加入洽詢
LOCATIONS

服務據點

北北基/宜蘭/花蓮
洽詢車

你的洽詢車總計 0 件產品

依據歐盟施行的個人資料保護法,我們致力於保護您的個人資料並提供您對個人資料的掌握。
按一下「全部接受」,代表您允許我們置放 Cookie 來提升您在本網站上的使用體驗、協助我們分析網站效能和使用狀況,以及讓我們投放相關聯的行銷內容。您可以在下方管理 Cookie 設定。 按一下「確認」即代表您同意採用目前的設定。
管理Cookies

隱私權偏好設定中心

依據歐盟施行的個人資料保護法,我們致力於保護您的個人資料並提供您對個人資料的掌握。
按一下「全部接受」,代表您允許我們置放 Cookie 來提升您在本網站上的使用體驗、協助我們分析網站效能和使用狀況,以及讓我們投放相關聯的行銷內容。您可以在下方管理 Cookie 設定。 按一下「確認」即代表您同意採用目前的設定。
查看隱私權政策

管理同意設定

必要的Cookie

一律啟用
網站運行離不開這些 Cookie 且您不能在系統中將其關閉。通常僅根據您所做出的操作(即服務請求)來設置這些 Cookie,如設置隱私偏好、登錄或填充表格。您可以將您的瀏覽器設置為阻止或向您提示這些 Cookie,但可能會導致某些網站功能無法工作。